文献速递细胞病理与分子病理

重新评估浆液性积液细胞学中恶性肿瘤检测的最佳送检量

Reassessing the optimal volume for malignancy detection in serous fluid cytology.
PubMed 文献 · Cancer Cytopathol · 2022-04-25

本研究基于8530例浆液性积液细胞学病例,分析送检液体体积对标本满意率及恶性诊断率的影响。结果显示,不满意、非典型和阴性病例的平均体积显著低于阳性病例,胸腹腔积液恶性诊断百分比随体积增加而升高,至75-100 mL范围显著增加。结论认为体积与满意率和恶性检测显著相关,胸腹腔积液至少应送检75-100 mL以获得最佳恶性诊断。

要点

  • 浆液性积液送检体积与标本满意率及恶性检出率显著相关。
  • 胸腹腔积液恶性诊断百分比在体积增至75-100 mL时显著升高。
  • 建议胸腹腔积液至少送检75-100 mL以优化恶性诊断。

核心结论

  • 浆液性积液细胞学中,送检体积与标本满意率及恶性检测显著相关。
  • 胸腹腔积液恶性诊断百分比随体积增大而升高,至少应送检75-100 mL以获得最佳恶性诊断。

研究设计与样本

  • 回顾性研究,从实验室信息系统识别8530例浆液性积液细胞学病例。
  • 按TIS分类用ANOVA Games-Howell检验比较平均送检体积差异。
  • 按0-5、5-10、10-25、25-50、50-75、75-100、100-150、150-250、250-500、500-2000 mL体积范围,用卡方检验比较胸腹腔积液恶性诊断百分比,并进行SiZer分析。

主要发现

  • 不满意、非典型和阴性病例的平均液体体积显著低于阳性病例。
  • SiZer分析显示胸腹腔积液恶性比例与液体体积呈正相关关系。
  • 胸腹腔积液样本的恶性诊断百分比在体积增至75-100 mL范围时显著增加。

关键数值与推荐

  • TIS建议送检至少50-75 mL浆液性积液以减少假阴性结果。
  • 本研究认为胸腹腔积液至少应送检75-100 mL以获得最佳恶性诊断。

临床怎么用

  • 临床送检胸腹腔积液细胞学时应至少采集75-100 mL以提高恶性检出率。
  • 体积不足可能降低标本满意率并增加假阴性风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The international system for reporting serous fluid cytopathology (TIS) recommends submitting at least 50-75 mL of serous fluid to decrease false-negative results. However, prior studies did not agree on specific volume requirements or consensus adequacy criteria. Our study aims to assess whether fluid volume affects the adequacy rate and to assess the minimum volume necessary for optimal adequacy in pleural and peritoneal fluids. METHODS: A total of 8530 serous fluid cytology cases were identified in the laboratory information system. Differences in mean fluid volume received in the laboratory were compared using an ANOVA Games-Howell test based on TIS category. The percentage of malignant diagnoses across the volume ranges of 0 to 5 mL, 5 to 10 mL, 10 to 25 mL, 25 to 50 mL, 50 to 75 mL, 75 to 100 mL, 100 to 150 mL, 150 to 250 mL, 250 to 500 mL, 500 to 2000 mL was compared in pleural and peritoneal fluids using a chi-square test, and a SiZer analysis was performed. RESULTS: Mean fluid volume in inadequate, atypical, and negative cases was significantly lower compared to positive cases. A SiZer analysis showed a positive relationship between the malignancy fraction of pleural and peritoneal fluids and fluid volume. The percentage of malignant diagnoses in pleural and peritoneal fluid samples increased significantly up to a volume range of 75-100 mL. CONCLUSIONS: There is a significant relationship between fluid volume, adequacy and detection of malignancy in serous effusion cytopathology. The malignancy fraction increases with larger fluid volumes but at least 75-100 mL of fluid should be submitted for optimal diagnosis of malignancy in pleural and peritoneal fluids.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Coconubo DM, Baskota SU, Li R, et al. Reassessing the optimal volume for malignancy detection in serous fluid cytology. Cancer Cytopathol. 2022. PMID: 35468659. doi:10.1002/cncy.22577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。